Navigation Links
CorePharma Addresses Violations in FDA Warning Letter
Date:5/28/2013

MIDDLESEX, N.J., May 28, 2013 /PRNewswire/ -- CorePharma LLC ("CorePharma"), a developer, manufacturer, and marketer of targeted generic prescription pharmaceuticals, announced today that it has addressed the violations contained in its June 2010 Warning Letter issued by the Food and Drug Administration.  These corrective actions provide a strong operational foundation for the business and have resulted in the FDA issuing a closeout letter to the firm, dated May 3, 2013.

Stephen White , the CEO of CorePharma said, "This is a significant achievement by CorePharma and is the result of a major commitment by our entire team to ensure compliance in a sustainable fashion.  We look forward to continuing to serve our customers and growing our business while at all times adhering to the corrective actions we now have in place."

About CorePharma

CorePharma, Middlesex, NJ, is a developer, manufacturer and marketer of targeted generic prescription pharmaceuticals across a variety of dosage forms and therapeutic categories. CorePharma operates four state-of-the-art facilities, totaling 115,000 square feet of space, in Middlesex, NJ.  The company actively seeks partnerships, licensing and acquisition opportunities to complement and expand its product portfolio. RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, owns a majority share of CorePharma.


'/>"/>
SOURCE CorePharma LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. OrbusNeich Launches Worlds First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents
2. CVS Caremark CEO Addresses Economic Club of Pittsburgh on Reinventing Pharmacy for Better Health
3. Issue Brief Addresses Stage 2 Meaningful Use Patient Education and Engagement Initiatives
4. Generex Addresses Recent Trading Volume in Shares of its Common Stock
5. ACEP Commends Congress For Passing Legislation That Addresses Drug Shortages As Well As "Bath Salts"
6. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
7. Student of Liver And Vascular Surgery of West China Hospital of Sichuan University Addresses The 18th ILTS Annual Meeting in the United States
8. Federal Government Targets Small, Mid-sized Practices for Probes of Patient Privacy Violations
9. TorkLaw Responds to FDA Warning Letter to St. Jude Medical Regarding Defective Heart Device; Now Representing Patients in 15 States
10. Physician-Patient Alliance for Health & Safety: Addressing The Joint Commission Opioid Warnings Can Reduce Respiratory Depression and Improve Patient Safety in Hospitals
11. First Warning Systems Receives Investment by Members of the Reno Angels and Local Investors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Dec 9, 2016 Research and Markets ... 2016-2020" report to their offering. ... The report forecasts the global optical transceiver ... 2016-2020. The report covers the present scenario and ... To calculate the market size, the report considers the revenue generated ...
(Date:12/9/2016)... Dec. 9, 2016  Harmar Mobility, LLC announced today that Steven ... of the Board of Directors. Photo - http://photos.prnewswire.com/prnh/20161209/447552 ... ... Mr. Dawson,s executive career includes ... across a variety of industries. He brings to the company deep ...
(Date:12/9/2016)... Dec. 9, 2016 aTyr Pharma, Inc. (Nasdaq: ... of Physiocrine-based therapeutics to address severe, rare diseases, today announced that ... BMO Prescriptions for Success Healthcare Conference at the InterContinental Barclay Hotel ... 14, 2016, at 4:20 p.m. ET. About aTyr ... aTyr ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, ... announced today that a new solution for Emergency Departments (ED) has been added ... space in Emergency Department examination rooms, and with a simplified pallet of information ...
(Date:12/8/2016)... ... 08, 2016 , ... After enjoying record-breaking attendance at its ... its 33rd Annual Issues & Research Conference, March 2-3, 2017, at the ... conference is “Persistent Challenges and New Opportunities: Using Research to Accelerate the Dialogue." ...
(Date:12/8/2016)... Plainsboro, NJ (PRWEB) , ... December 08, 2016 , ... ... patients, cancer centers and advocacy groups, has aligned with Upstage Lung Cancer in efforts ... In making the announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored ...
(Date:12/8/2016)... ... December 08, 2016 , ... Launching of ... Unified Instance Manager architecture, meeting the needs of multichannel growth and doubling ... unattended auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, administrative ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged ... in mind, SIGVARIS has created a new line of anti-embolism stockings to help ... provide the benefits of graduated compression when transitioning from recovery to early rehabilitation. ...
Breaking Medicine News(10 mins):